Shandong Sinobioway Biomedicine (002581.SZ) intends to sign a purchase contract with Jiangsu Su Hao. The total contract price is 53,978,000 yuan.
(002581.SZ) released an announcement, its wholly-owned subsidiary Shandong Yando Biotechnology Co., Ltd. ("...
Shandong Sinobioway Biomedicine (002581.SZ) announced that its wholly-owned subsidiary Shandong Yandu Biotechnology Co., Ltd. ("Shandong Yandu") intends to sign a "Buy-Sell Contract" with Jiangsu Su Hao Innovative Technology Group Co., Ltd. ("Jiangsu Su Hao") to purchase the supporting liquid storage system, chromatography system, filling materials, and reaction bags needed for the production workshop of the recombinant human nerve growth factor eye drops in the Shandong Weiming Biomedical Industry Park project. The total contract price is 53.978 million yuan.
Related Articles

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


